共 16 条
[1]
The relationship between tumour site, clinicopathological characteristics and cancer‐specific survival in patients undergoing surgery for colorectal cancer[J] . A. G. M. T. Powell,R. Wallace,R. F. McKee,J. H. Anderson,J. J. Going,J. Edwards,P. G. Horgan.Colorectal Disease . 2012 (12)
[3]
Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers[J] . Petr Ricanek,Stephan Brackmann,G&oslash,ri Perminow,Lars G. Lyckander,Jon Sponheim,&oslash,yvind Holme,Ole H&oslash,ie,Andreas Rydning,Morten H. Vatn.Scandinavian Journal of Gastroenterology . 2011 (9)
[5]
Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease[J] . J.P. Gisbert,A.G. McNicholl.Digestive and Liver Disease . 2008 (1)
[9]
Fecal Calprotectin: Validation as a Noninvasive Measure of Bowel Inflammation in Childhood Inflammatory Bowel Disease[J] . Susan K. Bunn,W. Michael Bisset,Margaret J. C. Main,Elizabeth S. Gray,Shona Olson,Barbara E. Golden.Journal of Pediatric Gastroenterology and Nutrition . 2001 (1)
[10]
A New Fecal Calprotectin Test for Colorectal Neoplasia: Clinical Results and Comparison with Previous Method[J] . B. Johne, O. Kronborg, H. I. T&oslash,n, J. Kristinsson, P. Fuglerud.Scandinavian Journal of Gastroenterology . 2001 (3)